2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow AnaMar AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects AM1476, Placebo - Safety, Tolerability | Phase 1 | Completed | AnaMar AB | 97 | 2020-12-16 | 2024-08-02 |
| A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis AM1030-CREAM or placebo - Atopic Dermatitis | Phase 1 / Phase 2 | Completed | AnaMar AB | 36 | 2014-11-01 | 2015-12-11 |
| AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects AMAP102 - Healthy Volunteers | Phase 1 | Terminated | AnaMar AB | 40 | 2009-04-01 | 2009-10-15 |
United Kingdom (3)
Dr Joseph Chiesa, MD FFPM FICR CSci (1) · Jim Bush (1)
2008 (1), 2014 (1)